|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-3-28
|
|
pubmed:abstractText |
The study was designed to elucidate regional brain metabolic changes according to a treatment and their relationship with neuropsychological performance changes in obsessive-compulsive disorder (OCD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0001-690X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
291-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12662252-Adult,
pubmed-meshheading:12662252-Brain,
pubmed-meshheading:12662252-Cerebellum,
pubmed-meshheading:12662252-Cognition,
pubmed-meshheading:12662252-Female,
pubmed-meshheading:12662252-Fluorodeoxyglucose F18,
pubmed-meshheading:12662252-Frontal Lobe,
pubmed-meshheading:12662252-Glucose,
pubmed-meshheading:12662252-Humans,
pubmed-meshheading:12662252-Male,
pubmed-meshheading:12662252-Mental Recall,
pubmed-meshheading:12662252-Neuropsychological Tests,
pubmed-meshheading:12662252-Obsessive-Compulsive Disorder,
pubmed-meshheading:12662252-Parietal Lobe,
pubmed-meshheading:12662252-Radiopharmaceuticals,
pubmed-meshheading:12662252-Tomography, Emission-Computed,
pubmed-meshheading:12662252-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder.
|
|
pubmed:affiliation |
Department of Psychiatry, Seoul National University Hospital, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
